30
Mar
The largest breast AI study to date shows value of Transpara in mammographic screening
The largest breast AI study to date shows value of Transpara in mammographic screening
In a recent study, the Cancer Registry of Norway used over 120,000 screening examinations from a population-based program to assess potential of using AI in screening. The study, published in Radiology, looked at 122,969 screening examinations from 47,877 women performed at four facilities of BreastScreen Norway.